Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
about
Idiopathic pulmonary fibrosis.Immunomodulatory agents for idiopathic pulmonary fibrosisCombined pulmonary fibrosis and emphysema syndrome: a reviewAnti-cytokine therapy in fibrosing alveolitis: where are we now?Idiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological dataClinical advances in the diagnosis and therapy of the interstitial lung diseases.Beware the steroid responsive nature of a pyrexial illnessIn search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up.Double-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia - short term evaluation of safety and tolerability.Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention studyOxidants/antioxidants in idiopathic pulmonary fibrosis.Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.Objective cough frequency in Idiopathic Pulmonary Fibrosis.Interferon gamma-1b therapy for cryptogenic fibrosing alveolitisReview of cryptogenic fibrosing alveolitis, including current treatment guidelinesRecent advances in the aetiology of cryptogenic fibrosing alveolitis.Gender influences the response to experimental silica-induced lung fibrosis in miceGenetics and early detection in idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival.Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group.Mechanical induction of cough in Idiopathic Pulmonary Fibrosis.What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts.A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitisFibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritisCryptogenic fibrosing alveolitis with preserved lung volumes.Idiopathic pulmonary fibrosis: current and future treatment options.Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea.Smoking and idiopathic pulmonary fibrosisManagement of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.Alveolitis: the key to the interstitial lung disorders.The larger bronchi in cryptogenic fibrosing alveolitis: a morphometric study.Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimensPrognosis of cryptogenic fibrosing alveolitis.Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivityComputed tomography based estimates of regional gas and tissue volume of the lung in supine subjects with chronic airflow limitation or fibrosing alveolitis.
P2860
Q21202895-27883657-A44F-4AE7-8978-3203DA046E4BQ24248714-57F9115A-A8C0-4515-AE22-279D9BEE8212Q24614740-8BA26506-87A1-40A3-AB85-AF2C27BA84C8Q24790968-252891D0-06C1-4692-B0F3-74D670FC7CFAQ30662543-6648E995-2E3B-4B7C-94FD-DAE12770673BQ33214781-0C273E77-DB10-4469-AC98-3B2F188861F3Q33578058-2A4EE32E-5F53-41C0-8A87-162829C57708Q33588114-47362CE9-C7CD-4DD7-802B-8E277558A610Q33589360-D3CEEC3B-B55F-4588-A543-9293301A337DQ33604601-217695A9-89D9-4822-93B9-09B21E2229AAQ33657810-55FD1F19-8356-497A-90E7-23E96B8E13B4Q33684184-3236E61D-C14C-462C-805F-CAF7F2B01994Q33821300-FDEC1579-3D14-45ED-B152-B83E01D403DFQ33955628-18957E5D-29B4-4002-BE1C-1251285947B0Q33986351-34764EA6-2660-4C82-9EFE-2B53359B4FE6Q34004430-7B6D525B-95E8-4B65-80B8-B134192DB201Q34048271-C5EC4AAC-FFD0-43B0-BFD0-65E703DB2201Q34105545-4337F871-9176-48E1-9186-B7035DD91AA8Q34305413-EEF855A9-B8A0-4D02-9050-A5C1DA7F295FQ34479395-DCA95B38-7864-4AE4-8C8E-205207A2F203Q34508187-0F8E875A-9E08-4472-9ACE-020856A9C618Q34748983-BE3771A7-56C8-48BE-9DC5-2532277C6BA8Q34980774-47D1D056-C5E7-4F10-8D3B-23A44B0B10DCQ35170988-B50E8E0D-C567-4E9F-807E-5DFD4470F7A7Q35532508-7097F8A6-5FEB-4682-8CCF-0F9A1614A107Q35534550-2A910ABA-232A-450E-B3AB-611F56AA007FQ35534651-4A7F584E-8B2E-4B34-8FBB-0256DFAF6B7CQ35551602-A4B11B44-459E-4F99-8622-99F1A1EF64C8Q35563250-31A3D643-3B8F-435D-A979-D78CF3BCD908Q35627863-A7603F26-7CD3-4944-8E90-8DEAAC4F1532Q35741750-47B632AB-E355-4378-879F-5F82D6641CD3Q35788811-3937EA6B-337A-4416-9B61-75DC76669E8EQ35801391-57EFCE49-4607-47EB-AD4C-076AD2A36874Q35847544-0F1E00F6-ED04-4285-AB22-FF3A85C035EBQ36117574-66367421-9930-45A0-B53B-D2B0EEF7572BQ36124439-764437CA-44C5-4054-8CC8-644400542DDDQ36126332-C606F7CD-7D61-4D1D-83DA-7E07E7BBE1EAQ36128128-499C224D-C311-4899-B4CC-6A90E998B292Q36146109-E658DFF9-FB2B-45FA-AC0A-0ACE55AE0F62Q36161121-1C9ED113-F1A2-4E5B-BC65-46AFD3FB6320
P2860
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@ast
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@en
type
label
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@ast
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@en
prefLabel
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@ast
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@en
P2093
P2860
P356
P1433
P1476
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival
@en
P2093
Turner-Warwick M
P2860
P304
P356
10.1136/THX.35.3.171
P407
P577
1980-03-01T00:00:00Z